Vijaya Diagnostic Centre Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
February 13, 2023 at 08:39 am
Share
Vijaya Diagnostic Centre Limited reported earnings results for the third quarter and nine months ended December 31, 2022. For the third quarter, the company reported sales was INR 1,131.19 million compared to INR 1,107.76 million a year ago. Revenue was INR 1,166.77 million compared to INR 1,139.77 million a year ago. Net income was INR 163.64 million compared to INR 252.87 million a year ago. Basic earnings per share from continuing operations was INR 1.6 compared to INR 2.48 a year ago. Diluted earnings per share from continuing operations was INR 1.6 compared to INR 2.46 a year ago.
For the nine months, sales was INR 3,382.3 million compared to INR 3,461.7 million a year ago. Revenue was INR 3,478.62 million compared to INR 3,558.09 million a year ago. Net income was INR 571.39 million compared to INR 859.68 million a year ago. Basic earnings per share from continuing operations was INR 5.6 compared to INR 8.43 a year ago. Diluted earnings per share from continuing operations was INR 5.58 compared to INR 8.37 a year ago.
Vijaya Diagnostic Centre Limited is an India-based company. The Company is engaged in the business of providing comprehensive range of diagnostic services, spanning pathological investigations, basic and high-end radiology, nuclear medicine, and related healthcare services. The Company operates through the Diagnostic Services segment. Its services include clinical pathology, microbiology, hematology, serology, histopathology, cytogenetics, biochemistry, molecular diagnostics, computerized tomography (CT) scan, magnetic resonance imaging (MRI) scan, ultrasound, x-ray, cardiology, gastroenterology, nuclear medicine, pet CT, and MRI -3t. It operates approximately 121 diagnostic centers in 20 cities spread across India.